Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. 

In this episode Tim chats to Sean Hall, CEO at Medlab Clinical (ASX:MDC).

Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®.

MedLab recently reported good interim readouts on NanaBis, giving confidence for Phase III trial. NanaBis is an investigative novel analgesic for cancer patients comprising equal parts of CBD and THC encapsulated in Medlab’s patented delivery platform, NanoCelle. NanaBis is currently available for Australian patients under the Special Access Scheme (SAS), and launching in the UK under the Named Patient Program (NPP).

To hear Tim and Sean discuss all this and more, click below!


To hear more from Sean check out this episode of Stockhead’s 2023 Prepped and Primed

 

Read MoreHealthMedtech

Featured Companies

You might be interested in